Alle Studien
RekrutierungBEOBACHTEND

Fabry Disease Registry & Pregnancy Sub-registry

This study, called the Fabry Registry, is an international program that carefully watches the health of people living with Fabry disease. It's not a clinical trial testing new medicines; instead, it observes how the disease affects people, no matter what treatment they are receiving. The main goals are to learn more about Fabry disease, how it changes over time, and to help doctors develop better ways to care for patients. There's also a special part of the study for pregnant women with Fabry disease, called the Pregnancy Sub-registry, which tracks their health and their babies' health during and after pregnancy to understand the effects of Fabry disease and its treatments. In both parts, patients receive their usual care, and no experimental treatments are given.

Auf einen Blick

Status
Rekrutierung
Sponsor
Genzyme, a Sanofi Company
Einschreibeziel
9,000
Starten
31 Jul 2001
Geschätzte Fertigstellung
31 Jan 2034

Worum geht es in dieser Studie?

Imagine a big, ongoing medical record that helps doctors understand Fabry disease better. That's essentially what the Fabry Registry is. It's a worldwide program that collects information about people who have Fabry disease. The idea is to gather lots of details over time, like how the disease starts, how it changes in different people, and what treatments they receive. This helps medical experts see the bigger picture of Fabry disease, including how it affects women, and helps them figure out the best ways to care for patients.

This isn't a study where you'd be given a new, untested medicine. Instead, it's about observing and recording. You would continue to see your own doctor and receive the care they think is best for you. The information gathered from many patients helps researchers improve their understanding and guides doctors in making recommendations for patient care. It also helps check how safe and effective existing treatments, like Fabrazyme®, are in the long run.

There's also a special part called the Fabry Pregnancy Sub-registry. This is specifically for women with Fabry disease who are pregnant or have been pregnant. It collects details about their pregnancy, birth, and even the baby's health for up to three years after birth. This is very important for understanding how Fabry disease and its treatments might affect pregnancy and newborns. Like the main Registry, it's about observing, not about giving experimental treatments, and all care remains under your doctor's guidance.

Wichtige Erkenntnisse

  • This is an observation study, not a drug trial.
  • It helps doctors understand Fabry disease better.
  • It includes a special part for pregnant women with Fabry disease.
  • You continue with your regular doctor and treatments.
  • Your health information is collected to improve future care.
  • Sie können die Teilnahme jederzeit beenden, ohne dass dies Ihre medizinische Versorgung beeinträchtigt.

Wer könnte berechtigt sein?

To join the main Fabry Registry, you must have a clear diagnosis of Fabry disease. This means your doctor has confirmed the diagnosis through specific tests, like checking for a particular enzyme activity or a gene change linked to Fabry disease.

If you're a woman with Fabry disease and are pregnant or have been pregnant, you might also be able to join the Fabry Pregnancy Sub-registry. To do so, you first need to be part of the main Fabry Registry.

Good news – there are no reasons that would prevent you from joining either part of this study once you meet the main requirements. All ages and both sexes are welcome in the main registry.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Do you have a confirmed diagnosis of Fabry disease?
  2. Are you willing to share your routine medical information?
  3. If you are pregnant or have been pregnant, are you also in the main Fabry Registry?
  4. Are you willing for information about your pregnancy and/or baby to be tracked?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

If you decide to take part in this study, you won't be given any new or experimental medications. Instead, your doctors will simply share information about your regular medical check-ups and treatments with the study. This means you'll continue to receive your usual care from your own doctor, just as you do now. The study is about collecting information from your routine visits, not adding extra tests or appointments specifically for the study.

If you join the Pregnancy Sub-registry, information about your medical history, your pregnancy (like how it's progressing), and the birth of your baby would be collected. If you agree, information about your baby's growth and health would also be collected until they are three years old. The total duration of your participation depends on how long you remain under care for Fabry disease and, for the pregnancy part, for up to three years after your baby is born.

Potenzielle Risiken und Vorteile

The main benefit of taking part is contributing to a better understanding of Fabry disease, which can help improve care for yourself and others in the future. As no experimental treatments are given, there are no additional medical risks beyond your usual care. The main involvement is sharing your health information. Your privacy is important, and steps are taken to protect your personal details. You are free to withdraw from the study at any time without it affecting your medical care.

Locations (284)

  • University Of Alabama Birmingham- Nephrology- Site Number : 840018
    Verifizierte Postleitzahl
    Birmingham, Vereinigte Staaten· Abgeschlossen
  • University Of Alabama Birmingham- Nephrology- Site Number : 840073
    Verifizierte Postleitzahl
    Birmingham, Vereinigte Staaten· Rekrutierung
  • Phoenix Children's Hospital- Site Number : 840003
    Verifizierte Postleitzahl
    Phoenix, Vereinigte Staaten· Rekrutierung
  • University of Arizona- Site Number : 840015
    Verifizierte Postleitzahl
    Tucson, Vereinigte Staaten· Rekrutierung
  • Arkansas Children's Hospital- Site Number : 840109
    Verifizierte Postleitzahl
    Little Rock, Vereinigte Staaten· Rekrutierung
  • University of Arkansas for Medical Sciences- Site Number : 840113
    Verifizierte Postleitzahl
    Little Rock, Vereinigte Staaten· Rekrutierung
  • Southern California Permanente Medical Group- Site Number : 840108
    Verifizierte Postleitzahl
    Los Angeles, Vereinigte Staaten· Rekrutierung
  • Usc Health Sciences Center Dept Of Genetics- Site Number : 840082
    Verifizierte Postleitzahl
    Los Angeles, Vereinigte Staaten· Abgeschlossen
  • University Of California Los Angeles- Site Number : 840088
    Verifizierte Postleitzahl
    Los Angeles, Vereinigte Staaten· Rekrutierung
  • UCSF Benioff Children's Hospital - Oakland- Site Number : 840029
    Verifizierte Postleitzahl
    Oakland, Vereinigte Staaten· Abgeschlossen
  • Children's Hospital of Orange County- Site Number : 840074
    Verifizierte Postleitzahl
    Orange, Vereinigte Staaten· Rekrutierung
  • University of California Irvine Medical Center- Site Number : 840036
    Verifizierte Postleitzahl
    Orange, Vereinigte Staaten· Rekrutierung

Häufige Fragen

What is Fabry disease?

Fabry disease is a rare genetic condition that can affect many parts of the body, causing a range of symptoms.

Will I receive new medicine in this study?

No, this study does not involve giving any new or experimental medicines. You will continue to receive the care your own doctor prescribes.

Warum ist diese Studie wichtig?

It helps medical experts learn more about Fabry disease, how it affects people over time, and develop better ways to care for patients.

Is my personal information kept private?

Yes, your privacy is a priority. Steps are taken to protect your personal medical information.

Kann ich die Studie jederzeit verlassen?

Yes, you are free to stop participating in the study at any point, and your decision will not affect your medical care.

Wie Sie mehr erfahren können

Trial Transparency

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Interessiert daran, teilzunehmen?

Registrieren Sie Ihr Interesse

Teilen Sie Ihre Details und das Forschungsteam für "Fabry Disease Registry & Pregnancy Sub-registry… wird Sie kontaktieren, wenn Sie möglicherweise infrage kommen. Sprechen Sie immer mit Ihrem Hausarzt, bevor Sie zustimmen, teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.